Related references
Note: Only part of the references are listed.Detection of Methicillin-Resistant Staphylococcus aureus Infections Using Molecular Methods
Fred C. Tenover et al.
ANTIBIOTICS-BASEL (2022)
Comparison of the global prevalence and trend of human intestinal carriage of ESBL-producing Escherichia coli between healthcare and community settings: a systematic review and meta-analysis
Yihienew M. Bezabih et al.
JAC-ANTIMICROBIAL RESISTANCE (2022)
National point prevalence study on carriage of multidrug-resistant microorganisms in Dutch long-term care facilities in 2018
Esther van Kleef et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2021)
Using Molecular Diagnostics to Develop Therapeutic Strategies for Carbapenem-Resistant Gram-Negative Infections
Fred C. Tenover
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)
Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study
Susan E. Dorman et al.
LANCET INFECTIOUS DISEASES (2018)
Decline in AmpC β-lactamase-producing Escherichia coli in a Dutch teaching hospital (2013-2016)
Evert den Drijver et al.
PLOS ONE (2018)
Plasmid-Mediated AmpC: Prevalence in Community-Acquired Isolates in Amsterdam, the Netherlands, and Risk Factors for Carriage
E. Ascelijn Reuland et al.
PLOS ONE (2015)
Population Distribution of Beta-Lactamase Conferring Resistance to Third-Generation Cephalosporins in Human Clinical Enterobacteriaceae in The Netherlands
Guido M. Voets et al.
PLOS ONE (2012)
Mortality following bacteraemic infection caused by extended spectrum beta-lactamase (ESBL) producing E-coli compared to non-ESBL producing E-coli
Mark Melzer et al.
JOURNAL OF INFECTION (2007)
Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing enterobacteriaceae: Importance of inadequate initial antimicrobial treatment
Mario Tumbarello et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)